Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Advocate Hospital System
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
patients must have clinically documented primary brain tumor for which resection is clinically indicated. Anticipated histology at resection should include:anaplastic astrocytoma, astrocytoma malignant NOS,brain stem glioma, ependymoma malignant, glioblastoma, glioblastoma multiforme, gliosarcoma, malignant oligodendroglioma, medulloblastoma, mixed astrocytoma-ependymoma
prior therapy is not a consideration in protocol entry
age unrestricted
ECOG performance status\<2(Karnofsky\>60%,)
life expectancy is not a consideration for protocol entry
patients must have normal organ and marrow function as defined below:
leukocytes \_\> 3,000/ml
absolute neutrophil count \_\>1,500/ml
platelets \>\_100,000/ml
total bilirubin:within normal institutional limits
AST (SGOT)/ALT (SGPT) \_\<2.5 X institutional upper limit of normal
creatinine:within normal institutional limits or creatinine clearance \>\_60 ml/min/1.73 m2 for patients with creatinine levels above institutional normal
women of child-bearing potential and men must agree to use adequate contraception(hormonal or barrier method of birth control;abstinence) prior to study entry and for the duration of study participation.
ability to understand and the willingness to sign a written informed consent document or have a parent or guardian with the ability to understand and the willingness to sign a written informed consent.
You may not be if
prior therapy is not an exclusion criterion
patients may not be receiving any other investigational agents history of allergic reactions attributed to compounds of similar chemical or biologic composition to aminolevulinic adic (ALA)
personal or family history of porphyrias
uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
pregnant women are excluded, breastfeeding should be discontinued if mother is treated with aminolevulinic acid.
